Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2014
10/21/2014US8865445 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
10/21/2014US8865431 Antigen binding domains
10/21/2014US8865430 Fusion polypeptides capable of activating receptors
10/21/2014US8865429 Increased oil content by increasing Yap1 transcription factor activity in oleaginous yeasts
10/21/2014US8865428 Protein production method, fusion protein, and antiserum
10/21/2014US8865174 Methods of treatment using human antibodies that bind IL-12
10/21/2014US8865165 Monoclonal antibody against group 2 allergen of Dermatophagoides pteronyssiuns, hybridoma cell line producing thereof, strip, kit and method using said monoclonal antibody for dust mite assay
10/16/2014US20140310836 Nucleic acid constructs and methods for producing altered seed oil compositions
10/16/2014US20140308704 Adenovirus producing novel cell line and the use thereof
10/16/2014US20140308702 Yeast recombinant cell capable of producing gdp-fucose
10/16/2014US20140308700 Hydrogenase polypeptide and methods of use
10/16/2014US20140308699 Yeast artificial chromosome carrying the mammalian glycosylation pathway
10/16/2014US20140308288 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
10/16/2014US20140308269 Humanized antibodies
10/14/2014US8859802 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
10/14/2014US8859739 Anti-huTNFR1 antibody and methods of use thereof for treatment
10/14/2014US8859738 Cytotoxic immunoglobulin
10/14/2014US8859737 Anti-HER3 antibodies and uses thereof
10/14/2014US8859254 Polypeptides having beta-glucosidase activity and polynucleotides encoding same
10/14/2014US8859253 Cellobiohydrolase variants and polynucleotides encoding same
10/14/2014US8859243 Method for producing an L-amino acid
10/14/2014US8859235 Methods in cell cultures, and related inventions, employing certain additives
10/14/2014US8859234 Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
10/14/2014US8859232 Genetically encoded photomanipulation of protein and peptide activity
10/14/2014US8859231 Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
10/14/2014US8859230 Polypeptides comprising an ice-binding activity
10/14/2014US8859229 Transient transfection with RNA
10/14/2014US8858941 VEGF/DLL4 binding agents and uses thereof
10/14/2014US8858940 Amino acid sequences directed against the Angiopoietin/Tie system and polypeptides comprising the same for the treatment of diseases and disorders related to angiogenesis
10/09/2014WO2014165287A1 Hybridoma clones and monoclonal antibodies to fibroblast growth factor 4
10/09/2014WO2014163176A1 Method for producing ny-eso-1 protein
10/09/2014WO2014161284A1 Cell-penetrating polypeptides and uses thereof in drug delivery
10/09/2014WO2014161037A1 Antibodies against human ryk and uses therefor
10/09/2014US20140303077 Albumin fusion proteins
10/09/2014US20140302559 Rapid method for cloning and expression of cognate antibody variable region gene segments
10/09/2014US20140302558 Modified bordetella pertussis strains
10/09/2014US20140302557 Engineered lower eukaryotic host strains for recombinant protein expression
10/09/2014US20140302556 Controlling o-glycosylation in lower eukaryotes
10/09/2014US20140302555 Reduced Genome Bacteria With Improved Genetic Stability
10/09/2014US20140302553 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues
10/09/2014US20140302519 Endoglycosidase from streptococcus pyogenes and methods using it
10/09/2014US20140302084 Immunogenic protein conjugates and method for making and using the same
10/09/2014US20140302018 Treatment of diffuse large-cell lymphoma with anti-cd20 antibody
10/08/2014EP2787083A2 Efficient production of peptides
10/08/2014EP2787081A1 Drug containing carrier into cell for forming immune complex
10/08/2014EP2787080A1 Promoter derived from human gene
10/08/2014EP2787078A1 Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain
10/08/2014EP2787075A1 Rodent capable of producing hybrid antibodies containing human variable regions and rodent constant regions
10/08/2014EP2785855A2 Microbial-based process for high-quality protein concentrate
10/08/2014EP2785854A1 Production of porphyrin-containing polypeptides in the presence of formate
10/08/2014EP2785197A1 Method for producing a protein hydrolysate
10/08/2014EP2785196A1 Methods and systems for protein refolding
10/07/2014US8853384 RNA interference mediating small RNA molecules
10/07/2014US8853381 Signal peptide for producing a polypeptide
10/07/2014US8853380 Modified SAK gene for the production of recombinant proteins
10/07/2014US8853374 Process for production of recombinant proteins as a soluble form
10/07/2014US8853370 Plant-produced glycoprotein comprising human-type sugar chain
10/07/2014US8853367 Compositions and methods for modulating rank activities
10/07/2014US8853365 Dual variable domain immunnoglobulins and uses thereof
10/07/2014US8853364 Prostate stem cell antigen (PSCA) variants and subsequences thereof
10/07/2014US8853363 Substance binding human IgG Fc receptor IIb (FcγRIIb)
10/07/2014US8853357 High purity lipopeptides
10/07/2014US8853179 Reengineering mRNA primary structure for enhanced protein production
10/07/2014US8853162 Interpenetrating polymer network comprising fibrin
10/07/2014US8853154 Fibronectin based scaffold domain proteins that bind to myostatin
10/07/2014US8853145 BLID; a novel protein domain for interaction with the Bcl-2 family of proteins
10/07/2014US8852939 Use of Vgll3 activity modulator for the modulation of adipogenesis
10/07/2014US8852917 Thuricin CD, an antimicrobial for specifically targeting Clostridium difficile
10/07/2014US8852912 Compositions and methods comprising alpha-amylase variants with altered properties
10/07/2014US8852909 Ketoreductase polypeptides for the reduction of acetophenones
10/07/2014US8852907 Conversion system for biomass
10/07/2014US8852899 Methods of making nylon intermediates from glycerol
10/07/2014US8852890 Production of bacterial strains
10/07/2014US8852889 Cell culture process
10/07/2014US8852888 Method of producing recombinant high molecular weight vWF in cell culture
10/07/2014US8852887 Antibodies against human tweak and uses thereof
10/07/2014US8852886 Host cells and methods of producing disulfide bond containing proteins
10/07/2014US8852866 Method for producing and identifying soluble protein domains
10/07/2014US8852612 Universal carrier for targeting molecules to Gb3 receptor expressing cells
10/07/2014US8852602 Immunological herpes simplex virus antigens and methods for use thereof
10/02/2014WO2014160790A1 Protein production method
10/02/2014WO2014160661A2 Systems and methods for the targeted production of a therapeutic protein within a target cell
10/02/2014WO2014160368A2 Compositions and methods for treating cancer
10/02/2014WO2014159850A2 Low-phosphate repressible promoter
10/02/2014WO2014159633A1 Recombinant polypeptide production
10/02/2014WO2014159580A1 Met-binding agents and uses thereof
10/02/2014WO2014159499A1 Methods of cell culture
10/02/2014WO2014159494A1 Methods of cell culture
10/02/2014WO2014159259A1 Methods for increasing mannose content of recombinant proteins
10/02/2014WO2014158770A1 Ribotoxin molecules derived from sarcin and other related fungal ribotoxins
10/02/2014WO2014157483A1 Medium additive for cell culture
10/02/2014WO2014157429A1 Method for producing protein
10/02/2014WO2014157077A1 Euglena spp. microalgae, polysaccharide manufacturing method, and organic compound manufacturing method
10/02/2014WO2014154930A1 Anti-factor b antibody, pharmaceutical composition that can be used for the treatment of diseases of the complement system, and uses thereof
10/02/2014US20140296151 Peptides from fish gelatine
10/02/2014US20140295497 Vectors and host cells comprising a modified sv40 promoter for protein expression
10/02/2014US20140295495 Methods of Preventing and Removing Trisulfide Bonds
10/02/2014US20140295493 Polypeptides Having Protease Activity and Polynucleotides Encoding Same
10/02/2014US20140295492 Methods for Cell-Free Protein Synthesis
10/02/2014US20140294885 Heterologous expression of neisserial proteins
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 1125